Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
70 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
000310-CH
A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy for Congenital Adrenal Hyperplasia through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human
Recruitment has not started
18-125 Years
NICHD
Congenital Night
16-EI-0024
Rod and Cone Mediated Function in Retinal Disease
Participants currently recruited/enrolled
5-125 Years
NEI
Night Blindness
16-CH-0164
A Phase III Extension Study of Efficacy, Safety and Tolerability of Chronocort (Registered) in the Treatment of Congenital Adrenal Hyperplasia
Completed Study; data analyses ongoing
18-80 Years
NICHD
Congenital Night
001085-D
Phase 2 Study of the PTH-Independent Effects of Encaleret on Mineral Homeostasis in Subjects with Post-Surgical Hypoparathyroidism (PSH)
Recruitment has not started
18-125 Years
NIDCR
Night
000923-H
Observational Study of Cardiac Arrhythmias in Subjects Treated with BTK Inhibitors
Participants currently recruited/enrolled
18-110 Years
NHLBI
Stationary
000911-DK
Dinner Time for Obesity and Prediabetes (DTOP)
Recruitment has not started
18-50 Years
NIDDK
Night
000906-I
A Phase 2 Randomized, Double-Blinded Cross-Over Design Study of the Early Metabolic Effects of Dolutegravir or Tenofovir Alefenamide in Healthy Volunteers
Recruitment has not started
18-55 Years
NIAID
Night
000780-D
A Phase 2 Study of Denosumab for Prevention of Skeletal Disease Progression in Children with Fibrous Dysplasia
Participants currently recruited/enrolled
4-14 Years
NIDCR
Night
000756-DK
Phase II Study of Growth Hormone Inhibition Using Pegvisomant In Severe Insulin Resistance
Participants currently recruited/enrolled
18-65 Years
NIDDK
Night
000754-M
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
Participants currently recruited/enrolled
12-70 Years
NIMH
Stationary
000740-CH
A Phase 3 Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Chronocort in the Treatment of Participants Aged 16 Years and Over with Congenital Adrenal Hyperplasia
Enrolling by Invitation
18-125 Years
NICHD
Congenital
000617-DK
A Natural History Study of Metabolic Sizing in Health and Disease
Participants currently recruited/enrolled
10-125 Years
NIDDK
Night
000494-DK
Natural History of Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
Participants currently recruited/enrolled
18-125 Years
NIDDK
Congenital
000423-C
Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults with Sickle Cell Disease (SCD): A Pilot Randomized Controlled Trial
Participants currently recruited/enrolled
18-55 Years
NCI
Night
000414-CH
Pilot Study of an Optic-to-Audio Device in a Pediatric Cohort with CLN3-related Conditions or Low Vision
Participants currently recruited/enrolled
6-18 Years
NICHD
Blindness
000411-CC
A Feasibility Pilot Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults with Congenital Adrenal Hyperplasia.
Recruitment has not started
16-22 Years
CC
Congenital
000350-D
Use of Clear Aligners for the Treatment of Dental Malocclusion In Individuals with Osteogenesis Imperfecta Types III and IV
Participants currently recruited/enrolled
12-40 Years
NIDCR
Night
000297-CH
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment
Participants currently recruited/enrolled
18-125 Years
NICHD
Congenital
000236-I
A Phase 1 Study of Empagliflozin as Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency
Participants currently recruited/enrolled
18-125 Years
NIAID
Congenital
000224-CH
Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea
Participants currently recruited/enrolled
3-12 Years
NICHD
Night
000051-N
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
Participants currently recruited/enrolled
48-70 Years
NINDS
Night
22-DK-0002
Effect of Ultra-processed versus Unprocessed Diets on Energy Metabolism
Participants currently recruited/enrolled
18-60 Years
NIDDK
Stationary
20-D-0122
A Phase IIb, Open-label Dose-ranging Study Evaluating the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX-305 (encaleret) in Autosomal Dominant Hypocalcemia Type 1 (ADH1)
No longer recruiting/follow-up only
16-125 Years
NIDCR
Night
20-CH-0126
Data Collection Study of Pediatric and Adolescent Gynecology Conditions
Participants currently recruited/enrolled
0-125 Years
NICHD
Congenital
20-CC-0113
Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons (COVID ARC 19)
No longer recruiting/follow-up only
18-80 Years
CC
Night
20-C-0070
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients with Inborn Errors of Immunity
Participants currently recruited/enrolled
4-69 Years
NCI
Congenital
19-H-0097
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Multiple Oral Doses of AG-348 in Subjects with Stable Sickle Cell Disease
Completed Study; data analyses ongoing
18-70 Years
NHLBI
Night
19-CH-0071
An Open-Label Phase 3 Study of the Safety and Efficacy of Pegvisomant in Children with Growth Hormone Excess
Participants currently recruited/enrolled
2-18 Years
NICHD
Night
19-CH-0020
A Phase 1-2 Multi-Center Study to Assess the Efficacy and Safety of Abiraterone Acetate as Adjunctive Therapy in Pre-Pubescent Children with Classic 21-Hydroxylase Deficiency
Recruitment has not started
2-9 Years
NICHD
Congenital
19-C-0085
Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Peripheral T cell Lymphoma
Clinical hold/Recruitment or enrollment suspended
12-125 Years
NCI
Congenital
18-N-0083
ASPIRO: A Phase 1/2/3, Randomized, Open-Label, Ascending-Dose, Delayed-Treatment Concurrent Control Clinical Study to Evaluate the Safety and Efficacy of AT132, an AAV8-Delivered Gene Therapy in X-Linked Myotubular Myopathy (XLMTM) Patients
No longer recruiting/follow-up only
3-5 Years
NINDS
Night
18-H-0108
Vascular Disease Discovery Protocol
Participants currently recruited/enrolled
2-100 Years
NHLBI
Stationary
18-DK-0044
Effect of Ultra Processed versus Unprocessed Diets on Energy Intake
Completed Study; data analyses ongoing
18-50 Years
NIDDK
Stationary
18-CC-0087
Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers
Completed Study; data analyses ongoing
18-65 Years
CC
Night
18-CC-0079
Pilot RCT of Web-based Behavioral Sleep Intervention for Individuals with Alcohol Use Disorder
Completed Study; data analyses ongoing
18-65 Years
CC
Night
18-C-0135
Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Participants currently recruited/enrolled
4-125 Years
NCI
Congenital
18-AA-0047
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
Clinical hold/Recruitment or enrollment suspended
18-60 Years
NIAAA
Night
17-H-0095
Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires
Participants currently recruited/enrolled
18-125 Years
NHLBI
Congenital
17-DK-N004
Energy Intake Response to Short-Term Alterations of Energy Expenditure in Humans
Participants currently recruited/enrolled
18-55 Years
NIDDK
Stationary
17-CH-0130
Break It Up: A Study Evaluating Breaking Up daily sedentary behavior in youth
Completed Study; data analyses ongoing
7-11 Years
NICHD
Night
17-C-0158
A Feasibility Study of Mobile Sensor Technologies to Assess General Symptomology of Cancer Patients
Enrolling by Invitation
18-125 Years
NCI
Night
16-N-0058
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Completed Study; data analyses ongoing
18-60 Years
NINDS
Stationary
16-N-0031
An All-Night Functional Magnetic Resonance Imaging Sleep Study With Auditory Stimuli
Participants currently recruited/enrolled
18-34 Years
NINDS
Night
16-C-0003
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Participants currently recruited/enrolled
4-75 Years
NCI
Congenital
16-AA-0059
Characterization of Brain Amyloid-beta (A-beta) Retention During Wakefulness And Following Emergence From Sleep In Healthy Subjects
Completed Study; data analyses ongoing
18-40 Years
NIAAA
Night
15-DK-0192
Quantifying Weight Regain and the Persistence of Metabolic Adaptation Following Extreme Weight Loss
Completed Study; data analyses ongoing
18-125 Years
NIDDK
Night
15-DK-0174
Dynamic Post-Prandial Metabolism in Patients with Non-Alcoholic Fatty Liver Disease
Completed Study; data analyses ongoing
18-125 Years
NIDDK
Night
15-DK-0108
Natural History of Noncirrhotic Portal Hypertension
Participants currently recruited/enrolled
12-125 Years
NIDDK
Congenital
15-AA-0127
(Epi)genetic Modulators of Fear Extinction in Alcohol Dependence
Participants currently recruited/enrolled
21-65 Years
NIAAA
Night
14-HG-0071
Clinical and Basic Investigations into Known and Suspected Congenital Disorders of Glycosylation
Participants currently recruited/enrolled
1-80 Years
NHGRI
Congenital
14-HG-0055
Study on Moebius Syndrome and Other Congenital Facial Weakness Disorders
Completed Study; data analyses ongoing
2-80 Years
NHGRI
Congenital
14-EI-0064
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions
Participants currently recruited/enrolled
1-125 Years
NEI
Congenital
14-DK-0060
Famine from Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes
Participants currently recruited/enrolled
18-65 Years
NIDDK
Blindness
14-AA-0187
Dopamine Rhythms in Health and Addiction
Clinical hold/Recruitment or enrollment suspended
21-55 Years
NIAAA
Night
13-EI-0049
Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma ( MAC)
Participants currently recruited/enrolled
1-125 Years
NEI
Blindness
11-EI-0147
Longitudinal Investigation of Dark Adaptation in Participants with Age-Related Macular Degeneration
Participants currently recruited/enrolled
50-125 Years
NEI
Night
11-CH-0078
Evaluation of Cortisol Resistance in Young Endurance-Trained and Elderly Men
Completed Study; data analyses ongoing
18-30 Years
NICHD
Night
10-HG-0065
Whole Genome Medical Sequencing for Gene Discovery
Participants currently recruited/enrolled
0-125 Years
NHGRI
Congenital
09-H-0225
Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia
No longer recruiting/follow-up only
2-125 Years
NHLBI
Congenital
08-C-0130
A Phase II Trial of Peginterferon alfa-2b (PEG-Intron) for Neurofibromatosis Type 1 Related Unresectable, Symptomatic or Life-Threatening Plexiform Neurofibromas
Completed Study; data analyses ongoing
0-21 Years
NCI
Congenital
07-DK-0115
Natural History of Type 2 Diabetes Mellitus in Children and Young Adults
Completed Study; data analyses ongoing
8-25 Years
NIDDK
Stationary
06-H-0072
Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Completed Study; data analyses ongoing
18-70 Years
NHLBI
Stationary
06-CH-0011
Natural History Study of Patients with Excess Androgen
Participants currently recruited/enrolled
0-99 Years
NICHD
Congenital
03-H-0282
Characterization of Cardiac Function in Subjects with Hereditary Hemochromatosis Who Are New York Heart Association Functional Class I
Completed Study; data analyses ongoing
21-100 Years
NHLBI
Stationary
03-H-0170
Nonmyeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Disease (SCD) and Beta-Thalassemia
Participants currently recruited/enrolled
2-125 Years
NHLBI
Congenital
02-C-0052
Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study
Participants currently recruited/enrolled
0-125 Years
NCI
Congenital
96-CH-0033
An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children with Congenital Adrenal Hyperplasia
No longer recruiting/follow-up only
2-18 Years
NICHD
Congenital
94-HG-0132
The Phenotype and Etiology of Proteus Syndrome
Participants currently recruited/enrolled
0-125 Years
NHGRI
Congenital
89-M-0006
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
Participants currently recruited/enrolled
3-125 Years
NIMH
Congenital
88-I-0083
Host Response to Infection and Treatment in the Filarial Diseases of Humans
Participants currently recruited/enrolled
3-100 Years
NIAID
Blindness